Compare Abbott Laboratories (ABT) vs S&P500 ETF (SPY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs S&P500 ETF — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while S&P500 ETF trades at $744.35. The key difference: Abbott Laboratories pays a 2.63% dividend while S&P500 ETF pays none, and S&P500 ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | SPY | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | — |
52-Week High | $136.62 | $759.55 |
52-Week Low | $82.57 | $620.34 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
SPY trades at $747.62, up 0.38% with technical indicators showing mixed signals - moving averages are bullish while oscillators suggest caution. The ETF is approaching key resistance at $750-$758 levels. Recent market sentiment reflects debate between AI-driven growth optimism and concerns about market leverage and valuations.
The outlook remains cautiously optimistic with S&P 500 targets ranging from 8,000-8,800 by year-end, though strategists warn of potential 10-20% corrections. Key risks include excessive market leverage, high valuations, and sector rotation away from tech. Earnings growth and reasonable valuations may support further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About S&P500 ETF
The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on SPY →
